Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 87 (12), 896-904

Artemisinin Derivatives Versus Quinine for Cerebral Malaria in African Children: A Systematic Review

Affiliations
Review

Artemisinin Derivatives Versus Quinine for Cerebral Malaria in African Children: A Systematic Review

Hmwe Hmwe Kyu et al. Bull World Health Organ.

Abstract

Objective: To summarize the existing evidence on the efficacy of artemether and arteether, two artemisinin derivatives, versus quinine for treating cerebral malaria in children.

Methods: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and the http://clinicaltrials.gov web site. We also checked the reference lists of existing systematic reviews and of all trials identified by the above methods. We searched exclusively for randomized controlled trials (RCTs) comparing artemether/arteether with quinine for treating cerebral malaria in children. Two independent reviewers assessed study eligibility and trial quality and extracted the data.

Findings: Nine RCTs were included in the analysis, and all were from Africa. Five had adequate allocation concealment. Seven trials compared artemether with quinine (1220 children), and two compared arteether with quinine (194 children). No statistically significant difference was found between artemisinin derivatives and quinine in preventing mortality (relative risk, RR: 0.91; 95% confidence interval, CI: 0.73-1.14; I(2): 0%). The quality of the evidence, as assessed by the Grade evidence profile, was moderate. The only serious adverse event was seen in a patient in the quinine group who developed fatal black water fever.

Conclusion: Artemisinin derivatives are not inferior to quinine in preventing death in children with cerebral malaria.

Figures

Fig. 1
Fig. 1
Identification of studies included in systematic review of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age
Fig. 2
Fig. 2
Forest plot of results of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age: mortality
Fig. 3
Fig. 3
Forest plot of results of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age: coma recovery time
Fig. 4
Fig. 4
Forest plot of results of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age: fever clearance time
Fig. 5
Fig. 5
Forest plot of results of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age: parasite clearance time
Fig. 6
Fig. 6
Forest plot of results of RCTs comparing artemisinin derivatives with quinine for treating cerebral malaria in African children ≤ 15 years of age: neurological sequelae

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

LinkOut - more resources

Feedback